Clinical trial
GH, IGF-I and Somatostatin Analogues in Hepatocellular Carcinoma
NCT00495846 · Federico II University, Other · Completed
Key facts
| NCT number | NCT00495846 |
|---|---|
| Title | GH, IGF-I and Somatostatin Analogues in Hepatocellular Carcinoma |
| Official title | Treatment of Advanced Hepatocellular Carcinoma With Depot Somatostatin Analogues: a Pilot Prospective Study Based on Somatostatin Receptors Tumors Expression |
| Acronym | SS-HCC |
| Lead sponsor | Federico II University, Other |
| Collaborators | Ospedali dei Colli |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Advanced Hepatocellular Carcinoma |
| Intervention type | Drug, Other |
| Interventions | Octreotide-LAR, Lanreotide Autogel, Locoregional treatments |
| Enrollment | 25 |
| Start date | Apr 1, 2007 |
| Primary completion | Apr 1, 2008 |
| Completion | Dec 1, 2008 |
| First posted | Jul 3, 2007 |
| Last update posted | Aug 17, 2009 |
| Countries | Italy |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: